Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis | MicrobiomeTrials← Back to trialsNCT07732075
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2028-10-30
Enrollment target: 384 participants